Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
Conditions: Adrenomyeloneuropathy Without Cerebral Involvement
Interventions: Procedure: Spinal cord stimulation
Sponsors: Third Military Medical University; Beijing Tiantan Hospital; Jingmen No.1 People's Hospital; The 958th Hospital of the Chinese People's Liberation Army
Recruiting
|
Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome
Conditions: Behcet Syndrome
Interventions: Drug: Corticosteroids + Rivaroxaban; Drug: Corticosteroids alone
Sponsors: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
|
Examination of Physiotherapists' Knowledge, Awareness and Competence on Physical Activity and Exercise in Hemophilia Patients
Conditions: Hemophilia
Sponsors: Gulhane School of Medicine
Recruiting
|
An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients
Conditions: Hemophilia A, Severe
Interventions: Biological: SKP-0141
Sponsors: SK Plasma Co., Ltd.
Not yet recruiting
|
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Conditions: Quality of Life (QOL); Patient-Reported Outcome Measures (PROMs); Pneumonia Childhood; Neuroblastoma (NB); Wilms Tumour; Immune Thrombocytopenic Purpura ( ITP )
Sponsors: RenJi Hospital; The EuroQol Research Foundation; Guizhou Provincial People's Hospital; Guizhou Medical University; The Children's Hospital of Zhejiang University School of Medicine; The Affiliated Hospital Of Guizhou Medical University
Not yet recruiting
|
An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment
Conditions: Von Willebrand Disease, Type 3
Interventions: Drug: Von Willebrand Factor Concentrates; Drug: Von Willebrand Factor Concentrates and Factor VIII Concentrates; Drug: Factor VIII Concentrates; Drug: Recombinant Activated Factor VII; Drug: Activated Prothrombin Complex Concentrate
Sponsors: Hoffmann-La Roche
Not yet recruiting
|
Synovial Proliferation on Routine Ultrasound: Active or Inactive?
Conditions: Haemophilia; Hemophilia a; Hemophilia B
Interventions: Other: Ultrasound imaging
Sponsors: Van Creveldkliniek
Not yet recruiting
|
Comparison of Saliva Biomarkers in Two Different Geographical Regions of Turkey
Conditions: Saliva; Cortisol; Smoking, Tobacco; Periodontal Bone Loss; Periodontal Disease; Periodontal Therapy
Interventions: Procedure: Non-Surgical Intervention; Diagnostic Test: Saliva Collection (Baseline); Other: Probing; Diagnostic Test: Saliva Collection (After treatment)
Sponsors: Karabuk University; Ataturk University; Ankara University
Completed
|
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Conditions: Haemophilia A, Haemophilia B
Interventions: Drug: Concizumab
Sponsors: Novo Nordisk A/S
Not yet recruiting
|
Impact of Prior Identification and Education of Patients Requiring a Digestive Stoma for Fecal Diversion
Conditions: Colorectal Anastomosis; Endometrial; Anastomotic Leak Rectum; Ulcerative Colitis (Disorder); Adenomatous Polyposis Coli, Familial; Crohn Disease; Digestive Cancers; Protectomy
Interventions: Other: preoperative stoma identification and education
Sponsors: Assistance Publique Hopitaux De Marseille
Not yet recruiting
|
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus; Inflammatory Myopathy; Systemic Sclerosis (SSc); ANCA-associated Vasculitis; IgG4-Related Diseases; Antiphospholipid Syndrome; Acquired Thrombotic Thrombocytopenic Purpura; Behcet Disease; Sjogren Syndrome
Interventions: Drug: BCMA-CD19 CAR-T therapy
Sponsors: Peking University People's Hospital
Recruiting
|
A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis
Conditions: Haemophilia A (Moderate or Severe); Hemophilia, Classic; Haemophilia; Hemophilia; Classic Hemophilia; Synovial Hypertrophy
Interventions: Drug: Efanesoctocog alfa
Sponsors: Swedish Orphan Biovitrum; PSI CRO
Recruiting
|
Early Genomic Testing for Inherited Bleeding Disorders
Conditions: Bleeding Disorder
Interventions: Genetic: Genetic testing for inherited bleeding disorders
Sponsors: Kingston Health Sciences Centre; Unity Health Toronto; The Ottawa Hospital
Not yet recruiting
|
KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors
Conditions: Hemophilia a and B
Interventions: Drug: KN057
Sponsors: Suzhou Alphamab Co., Ltd.
Not yet recruiting
|
Evaluation of Voice in Behcet's
Conditions: Behcet Disease
Interventions: Other: 1-Laryngyscopic examination 2-Acoustic analysis
Sponsors: Minia University
Not yet recruiting
|
Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Conditions: Hemophilia a with Inhibitor
Interventions: Drug: Advate®; Drug: Advate®; Drug: Advate®; Drug: Advate®; Drug: Advate®
Sponsors: Runhui WU
Recruiting
|
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Conditions: Von Willebrand Disease (VWD); Von Willebrand Disease (VWD), Type 1
Interventions: Drug: HMB-002 (Part A); Drug: HMB-002 (Part B)
Sponsors: Hemab ApS
Recruiting
|
Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children
Conditions: Hemophilia; Upper Extremity; Strength; Performance; Children
Sponsors: Hacettepe University
Enrolling by invitation
|
Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products
Conditions: Congenital Hemophilia A
Interventions: Biological: Recombinant single-chain factor VIII (rVIII-SingleChain)
Sponsors: CSL Behring
Recruiting
|
Manual Therapy in Hemophilic Arthropathy of the Ankle
Conditions: Hemophilia A
Interventions: Other: Manual Therapy; Other: Placebo
Sponsors: Investigación en Hemofilia y Fisioterapia
Recruiting
|
ATHNdataset Registry
Conditions: Hemophilia; Thrombosis; Hemophilia A; Hemophilia B; Sickle Cell Disease; Glanzmann Thrombasthenia; Bleeding Disorder; Blood Disorder; Von Willebrand Diseases
Sponsors: American Thrombosis and Hemostasis Network
Enrolling by invitation
|
To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia a
Conditions: Hemophilia a
Interventions: Drug: GS1191-0445 injection
Sponsors: Gritgen Therapeutics Co., Ltd.
Not yet recruiting
|
Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving FVIII Prophylaxis
Conditions: Hemophilia A
Interventions: Diagnostic Test: HEAD-US; Diagnostic Test: Urinary carboxy-terminal cross linked telopeptide of type II collagen; Diagnostic Test: Inflammatory markers
Sponsors: Chulalongkorn University
Enrolling by invitation
|